34
Participants
Start Date
November 6, 2020
Primary Completion Date
April 23, 2024
Study Completion Date
April 23, 2024
ANK-700
Intravenous (IV) infusion
Placebo
Intravenous (IV) infusion
Jefferson University Hospitals, Philadelphia
MS Center of Greater Washington, Vienna
Midlands Neurology & Pain Associates PA, Columbia
University of South Florida - Neurology, Tampa
Aqualane Clinical Research, Naples
North Central Neurology, Cullman
Advanced Neurosciences Institute, Franklin
Cleveland Clinic, Cleveland
University of Kansas Lander Center on Aging/ Neurology, Kansas City
Ochsner Clinic Foundation, New Orleans
University of Texas Southwestern, Dallas
University of Texas Health Science Center, Houston
UC Health Neurosciences Center, Aurora
Barrow Neurological Institute, Phoenix
MultiCare Health System, Tacoma
Lead Sponsor
Anokion SA
INDUSTRY